90 related articles for article (PubMed ID: 1746910)
1. Induction of tumor degeneration by sodium benzylideneascorbate.
Sakagami H; Asano K; Fukuchi K; Gomi K; Ota H; Kazama K; Tanuma S; Kochi M
Anticancer Res; 1991; 11(4):1533-8. PubMed ID: 1746910
[TBL] [Abstract][Full Text] [Related]
2. Effect of sodium benzylideneascorbate on chemically-induced tumors in rats.
Sakagami H; Takeda M; Utsumi A; Fujinaga S; Tsunoda A; Yasuda N; Shibusawa M; Koike T; Ota H; Kazama K
Anticancer Res; 1993; 13(1):65-71. PubMed ID: 8386496
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
Sakagami H; Satoh K; Kochi M
Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
[TBL] [Abstract][Full Text] [Related]
4. Role of hydrogen peroxide in antitumor activity induction by sodium 5,6-benzylidene-L-ascorbate.
Sakagami H; Hosaka M; Arakawa H; Maeda M; Satoh K; Ida Y; Asano K; Hisamitsu T; Takimoto M; Ota H; Inagaki M; Sasuga K; Sho S; Tanaka T; Utsumi N; Oi T; Kochi M
Anticancer Res; 1998; 18(4A):2519-24. PubMed ID: 9703903
[TBL] [Abstract][Full Text] [Related]
5. Induction of DNA fragmentation in human myelogenous leukemic cell lines by sodium 5,6-benzylidene-L-ascorbate and its related compounds.
Kuribayashi N; Sakagami H; Sakagami T; Niimi E; Shiokawa D; Ikekita M; Takeda M; Tanuma S
Anticancer Res; 1994; 14(3A):969-76. PubMed ID: 8074500
[TBL] [Abstract][Full Text] [Related]
6. Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate.
Asano K; Satoh K; Hosaka M; Arakawa H; Inagaki M; Hisamitsu T; Maeda M; Kochi M; Sakagami H
Anticancer Res; 1999; 19(1A):229-36. PubMed ID: 10226547
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific action of sodium 5,6-benzylidene-L-ascorbate in N-nitrosodiethylamine-administered mouse model.
Asano K; Satoh K; Kochi M; Kusama K; Sakagami H
Anticancer Res; 2001; 21(1A):281-4. PubMed ID: 11299747
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial control of cell death induction by sodium 5,6-benzylidene-L-ascorbate.
Fujii H; Amano O; Kochi M; Sakagami H
Anticancer Res; 2003; 23(2B):1353-6. PubMed ID: 12820394
[TBL] [Abstract][Full Text] [Related]
10. Sodium 5, 6-benzylidene-L-ascorbate induces in vitro neuronal cell differentiation accompanying apoptosis and necrosis.
Tashiro F; Sugiyama A; Urano Y; Kochi M
Anticancer Res; 2002; 22(3):1423-31. PubMed ID: 12168819
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ mobilization during cell death induction by sodium 5, 6-benzylidene-L-ascorbate.
Takahashi H; Sakagami H; Ohata H; Iida M; Momose K; Yamamura M; Takeda M
Anticancer Res; 1996; 16(5A):2629-34. PubMed ID: 8917362
[TBL] [Abstract][Full Text] [Related]
12. Antioxidative activity of benzylideneascorbate and its effect on adriamycin-induced cardiotoxicity.
Kojima S; Iizuka H; Yamaguchi H; Tanuma S; Kochi M; Ueno Y
Anticancer Res; 1994; 14(5A):1875-80. PubMed ID: 7847820
[TBL] [Abstract][Full Text] [Related]
13. Induction of DNA fragmentation by nicotine in human myelogenous leukemic cell lines.
Yoshida H; Sakagami H; Yamanaka Y; Amano Y; Yamaguchi M; Yamamura M; Fukuchi K; Gomi K; Ohata H; Momose K; Takeda M
Anticancer Res; 1998; 18(4A):2507-11. PubMed ID: 9703901
[TBL] [Abstract][Full Text] [Related]
14. Interaction between sodium 5,6-benzylidene-L-ascorbate and gallic acid.
Koyama N; Satoh K; Ida Y; Hiroi M; Oi T; Kochi M; Yamamoto Y; Sakagami H
Anticancer Res; 1999; 19(2A):1159-64. PubMed ID: 10368669
[TBL] [Abstract][Full Text] [Related]
15. Stability of sodium 5,6-benzylidene-L-ascorbate.
Sakagami H; Yamamura TS; Takahashi H; Shibuya I; Takeda M
Anticancer Res; 1995; 15(4):1269-74. PubMed ID: 7654007
[TBL] [Abstract][Full Text] [Related]
16. Benzylideneascorbate induces apoptosis in L929 tumor cells.
Tanuma S; Shiokawa D; Tanimoto Y; Ikekita M; Sakagami H; Takeda M; Fukuda S; Kochi M
Biochem Biophys Res Commun; 1993 Jul; 194(1):29-35. PubMed ID: 8333843
[TBL] [Abstract][Full Text] [Related]
17. Role of hydrogen peroxide in cytotoxicity induction by ascorbates and other redox compounds.
Iwasaka K; Koyama N; Nogaki A; Maruyama S; Tamura A; Takano H; Takahama M; Kochi M; Satoh K; Sakagami H
Anticancer Res; 1998; 18(6A):4333-7. PubMed ID: 9891488
[TBL] [Abstract][Full Text] [Related]
18. Effect on protein synthesis and cell survival of the benzaldehyde derivatives sodium benzylidene ascorbate (SBA) and the deuterated compound zilascorb(2H).
Pettersen EO; Larsen RO; Boerretzen B; Dornish JM; Oftebro R
Anticancer Res; 1991; 11(3):1077-81. PubMed ID: 1888141
[TBL] [Abstract][Full Text] [Related]
19. Interaction between sodium 5,6-benzylidene-L-ascorbate and dopamine.
Satoh K; Ida Y; Kochi M; Sakagami H
Anticancer Res; 1998; 18(5A):3565-9. PubMed ID: 9858940
[TBL] [Abstract][Full Text] [Related]
20. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
